Strategic fit Small biotech with a clear focus on genomic analysis platforms and NGS workflows presents a high-potential customer for RTG Core and RTG Tools, especially for labs seeking validated, cost-effective analytics either on-premises or via cloud.

Cloud and on‑prem Offerings include both on-site compute deployments and cloud access, enabling flexible procurement for research teams adopting hybrid IT strategies or transitioning to cloud-based genomics analysis.

Clinical expansion Past partnerships aimed at clinical-grade analysis tools and liquid biopsy capabilities indicate interest in translational and diagnostic applications, presenting opportunities for enterprise-grade analytics solutions and regulatory-aligned tooling.

Growth potential Revenue is under one million with eight million in funding, signaling a startup-ready engagement with potential for scalable licensing, custom integrations, and tiered support packages as they expand product adoption.

Tech and ecosystem Active collaboration history and a technology stack oriented toward scalable analytics, combined with a seasoned commercial team, suggests effective cross-sell opportunities around data management, workflow optimization, and enterprise deployment.